Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank50
5Y CAGR-68.1%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
-68.1%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
4 yr
Consecutive growthRecovering
PeriodValue
202417.35%
2023-22.41%
2022-40.91%
2021-118.76%
2020-257.03%
20195220.00%
201850.50%
201749.75%
2016-76.32%
2015-2412.84%